Lateral and Amazon Capital invest in Cambridge life sciences

Investment company Lateral has acquired a key site in Cambridge for £15 mln (€17.3 mln) from an overseas investor as part of its drive to deliver lab space to the life sciences sector.

Premium subscriber content – please log in to read more or take a free trial.


Latest news

Best read stories